Search

everythinglearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Polyamines help fix DNA damage accurately in cells.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Two impurities in finasteride were identified and characterized as cyclohexyl and phenyl analogs.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Certain drugs that block specific enzymes can help treat prostate diseases.

The study successfully identified the structure of finasteride.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

The research helps understand how finasteride works and aids drug development.

Methyl pyropheophorbide A from Sansevieria trifasciata leaves may help treat hair loss.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Finasteride's molecular properties and active sites were identified using computational methods.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Future wound dressings will be smart, multifunctional, and improve personalized medicine.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Smart microneedles can deliver drugs painlessly and accurately for diseases like diabetes and tumors.

Perilla frutescens, an East Asian plant, contains 400 bioactive compounds that have various health benefits, including anti-inflammatory, antidepressant, and anticancer effects, and can treat conditions like diabetes, skin allergies, and neurological disorders.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Asteraceae plants may help treat diabetes, but more research is needed.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.